Ryan Gill, PhD

Ryan is an experienced executive, company builder, strategist, and leader of diverse technical teams. He currently serves as CEO and Board Member at Artisan Bio, where he is responsible for all aspects of Artisan’s vision to design, build, and deliver precisely engineered cells for next-generation therapeutic applications. Over the past 2 decades, Ryan has envisioned and built a range of internationally recognized companies in the field of genome engineering. This includes roles as CEO, CSO, and Board Member at Inscripta, Inc.; founder at Biota Technology (acq. Novozymes 2021); and founder, advisor, and Board Member at OPXBIO (acq. Cargill 2015). Academically, Ryan built a world-class synthetic biology/DNA Foundry group at the University of Colorado and was the Scientific Director and NNF Laureate Fellow for DNA Foundries at the Novo Nordisk Foundation Center for Biosustainability in Denmark. Ryan is the inventor on foundational patents for Artisan, Inscripta, Inc. and OPXBIO.